ACM
XFOR icon

AIGH Capital Management’s X4 Pharmaceuticals XFOR Stock Holding History

AIGH Capital Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-33,257
Closed -$1.71M – 59
2022
Q3 		$1.71M Hold
33,257
– – 0.53% 28
2022
Q2 		$962K Hold
33,257
– – 0.25% 39
2022
Q1 		$1.75M Sell
33,257
-15,546
-32% -$892K 0.43% 31
2021
Q4 		$3.35M Sell
48,803
-6,682
-12% -$845K 1.02% 23
2021
Q3 		$8.8M Buy
55,485
+7,522
+16% +$1.24M 1.85% 16
2021
Q2 		$9.35M Buy
+47,963
New +$12.1M 1.68% 18

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
LCM
Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

AIGH Capital Management's XFOR Position: Q4 2022 in Review

AIGH Capital Management sold out of X4 Pharmaceuticals (XFOR) in Q4 2022, closing a stake of 33,257 shares — an estimated $1.71M sold.

AIGH Capital Management first reported a position in XFOR in Q2 2021 and held it in 6 quarters. The position peaked at $9.35M in Q2 2021. 52 funds tracked by Wall St. Rank hold XFOR as of Q4 2022.

  • AIGH Capital Management reported no remaining X4 Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • AIGH Capital Management sold 33,257 X4 Pharmaceuticals shares in Q4 2022, an estimated $1.71M.
  • AIGH Capital Management first reported a position in X4 Pharmaceuticals in Q2 2021 and held it in 6 quarters.
  • AIGH Capital Management's X4 Pharmaceuticals position peaked at $9.35M in Q2 2021.
  • 52 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q4 2022.

Based on AIGH Capital Management's 13F filing for Q4 2022, filed 15 Feb 2023.